Ozempic Shortage — Why You Can't Find It - The $16 Billion Bet to Build Enough

Ben Synth explores Novo Nordisk's unprecedented $16.5 billion manufacturing expansion to end the Ozempic shortage—from fermentation constraints and counterfeit threats to multi-continent factory builds racing against soaring demand. Will massive investments spanning 2027–2029 finally close the gap between a blockbuster molecule and millions needing it?Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.